Baltruškevičienė, E.; Mickys, U.; Žvirblis, T.; Stulpinas, R.; Pipirienė Želvienė, T.; Aleknavičius, E. Significance of KRAS, NRAS, BRAF and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Receiving Bevacizumab: A single Institution Experience. AML 2016, 23 (1), 24-34. https://doi.org/10.6001/actamedica.v23i1.3267.